Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

C9 Antikörper (AA 289-515)

Dieses Anti-C9-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von C9 in WB und ELISA. Geeignet für Human und Maus.
Produktnummer ABIN5692808

Kurzübersicht für C9 Antikörper (AA 289-515) (ABIN5692808)

Target

Alle C9 Antikörper anzeigen
C9 (Complement Component C9 (C9))

Reaktivität

  • 61
  • 2
  • 2
  • 2
  • 2
  • 2
Human, Maus

Wirt

  • 49
  • 13
  • 2
  • 1
Kaninchen

Klonalität

  • 51
  • 13
Polyklonal

Konjugat

  • 32
  • 7
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser C9 Antikörper ist unkonjugiert

Applikation

  • 49
  • 26
  • 25
  • 20
  • 13
  • 9
  • 9
  • 8
  • 7
  • 6
  • 6
  • 2
  • 2
  • 1
Western Blotting (WB), ELISA
  • Bindungsspezifität

    • 16
    • 9
    • 6
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 289-515

    Verwendungszweck

    Anti-Complement C9 Antibody Picoband®

    Marke

    Picoband™

    Kreuzreaktivität (Details)

    No cross-reactivity with other proteins.

    Produktmerkmale

    Rabbit IgG polyclonal antibody for Complement C9 detection. Tested with WB, Direct ELISA in Human,Mouse.

    Immunogen

    E. coli-derived human Complement C9 recombinant protein (Position: K289-N515).

    Isotyp

    IgG
  • Applikationshinweise

    Western blot, 0.1-0.5 μg/mL
    ELISA, 0.1-0.5 μg/mL
    1. Coto, E., Martinez-Naves, E., Dominguez, O., DiScipio, R. G., Urra, J. M., Lopez-Larrea, C.DNA polymorphism and linkage relationship of the human complement component C6, C7, and C9 genes. Immunogenetics 33: 184-187, 1991. 2. Hobart, M. J., Fernie, B. A., Wurzner, R., Oldroyd, R. G., Harrison, R. A., Joysey, V., Lachmann, P. J. Difficulties in the ascertainment of C9 deficiency: lessons to be drawn from a compound heterozygote C9-deficient subject. Clin. Exp. Immun. 108: 500-506, 1997.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

    Konzentration

    500 μg/mL

    Buffer

    Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg NaN3.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
    It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles.
  • Target

    C9 (Complement Component C9 (C9))

    Andere Bezeichnung

    C9

    Hintergrund

    Synonyms: Complement component C9,Complement component C9a,Complement component C9b,C9,

    Tissue Specificity: Plasma.

    Background: Complement component 9 is a protein involved in the complement system. It participates in the formation of the Membrane Attack Complex (MAC). The MAC assembles on bacterial membranes to form a pore, permitting disruption of bacterial membrane organization. Mutations in this gene cause component C9 deficiency. And this gene is mapped to 5p13.1.

    Molekulargewicht

    80 kDa

    Gen-ID

    735

    UniProt

    P02748

    Pathways

    Komplementsystem
Sie sind hier:
Chat with us!